We’re excited to announce that from December 13-16, Bruker Cellular Analysis will be an exhibitor at this year’s Antibody Engineering & Therapeutics Conference in San Diego. This premier event is dedicated to showcasing the latest advancements in antibody engineering, design, and selection. With a focus on diverse topics such as Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH, and more, the conference promises to be a hub of groundbreaking science and research.
Visit us at booth 401, where the Bruker Cellular Analysis team will be eager to engage in discussions about our flexible and customizable single cell platforms. Learn how these platforms can elevate your understanding of cellular function across various domains, including discovery, bioprocessing, clinical research, and therapy development.
Don’t miss our highlighted event on December 15th at 12:05 PM
Vincent Pai, Associate Director of Product Management at Bruker Cellular Analysis, will be presenting:
“Democratizing Access to Broad B Cell Diversity for Rapid Monoclonal Antibody Discovery from Humans and Beyond.”
Vincent will delve into the groundbreaking Opto® B Discovery application on the Beacon® optofluidic system. This innovative technology enables rapid selection of lead candidates by function-forward screening of B cells in under 1 week. This presentation will introduce Bruker Cellular Analysis’ newest antibody discovery offering for screening human memory B cells and share how customers can leverage our collective reagents, chips, and technology to rapidly discover high value monoclonal antibodies across many other species, including rat and camelids.
Join us for our poster session
We will also be presenting a poster, titled “Discovery of functional Rabbit Memory B Cell-derived antibodies using the Beacon® Optofluidic System.”
We extend an invitation to all conference attendees to stop by to discuss our poster, offering a closer look at the discovery of functional Rabbit Memory B Cell-derived antibodies through our cutting-edge Beacon® Optofluidic System.
Bruker Cellular Analysis is excited to be part of this year’s Antibody Engineering & Therapeutics Conference, and we look forward to sharing our expertise and innovations with you at booth 401, our presentation, and our engaging poster session. See you in San Diego!